Tesamorelin + NAD+ Stack — The Longevity Protocol UAE Researchers Quietly Run

Published 2026-06-25 · REVIVE Peptides Research Desk · 8 min read
TL;DR. Tesamorelin (a GHRH analog) drives pulsatile growth hormone and a 15.2% visceral fat reduction in 26 weeks (Stanley 2014). NAD+ tops up the cellular fuel and sirtuin pathways that GH pulses depend on. UAE longevity researchers stack the two for body recomposition without the blunt-tool side effects of exogenous GH. REVIVE LAB UAE keeps both vials — tesamorelin 5 mg / 10 mg and NAD+ 100 mg — in stock with same-day cold-chain delivery across Dubai, Abu Dhabi, and the rest of the Emirates.

If you are searching for the most-cited longevity peptide stack in the UAE, you already know the answer is quietly being run out of clinics in DIFC, longevity labs in Jumeirah, and serious home-research setups in Dubai Marina, Business Bay, and Abu Dhabi's Al Reem Island. The pairing is tesamorelin + NAD+ — and REVIVE LAB UAE is the peptides UAE supplier most of those researchers buy from. This guide walks through the mechanism, the dosing windows researchers use, the Stanley 2014 visceral fat data, and how to buy tesamorelin in Dubai with same-day delivery from a trusted peptides supplier UAE.

Why does this stack matter in 2026? Because the bluntest tool in the longevity toolkit — exogenous recombinant GH — is brute, expensive, and pulse-suppressing. Tesamorelin is the elegant alternative: a GHRH analog that asks your own pituitary to release GH in natural pulses. Layer NAD+ on top and you are restoring the cellular substrate (NAD/NADH) that those GH pulses, sirtuin activity, and mitochondrial repair all depend on. The result UAE researchers report: visceral adipose tissue (VAT) trending down, deep sleep trending up, recovery faster — without slamming the IGF-1 ceiling.

What tesamorelin actually does (and why Dubai longevity researchers care)

Tesamorelin is a synthetic 44-amino-acid GHRH analog. It binds the GHRH receptor on the anterior pituitary and triggers a pulsatile release of endogenous growth hormone — the operative word being pulsatile, because the body's GH receptor downregulates fast under continuous stimulation. That natural pulse architecture is preserved with tesamorelin, which is why it earned FDA approval for HIV-associated lipodystrophy.

The pivotal phase III data from Stanley and colleagues (2014, Journal of Clinical Endocrinology & Metabolism) tracked 26 weeks of 2 mg daily tesamorelin SC: visceral adipose tissue dropped 15.2% vs +5% in placebo, IGF-1 rose into the upper-normal band, and lean mass was preserved. Earlier work by Falutz (2007, NEJM; 2010 follow-up) had already established the VAT-selective mechanism. This is not a fat-burner — it is a body-composition redistributor.

Why the NAD+ pairing isn't optional for serious protocols

GH pulses cost energy. Sirtuins (SIRT1, SIRT3, SIRT6) — the longevity gene family activated downstream of GH/IGF-1 signaling — are NAD+-dependent deacetylases. As NAD+ declines with age (and it declines sharply after 40), the same GH pulse produces less downstream repair. Adding NAD+ 100 mg vials into the protocol restores that cofactor pool. Researchers tracking biomarkers in Dubai longevity setups report better sleep architecture (more N3) and faster soreness clearance on the combined stack vs tesamorelin monotherapy.

In stock today across the UAE.
REVIVE LAB UAE tesamorelin 5 mg and 10 mg vials, HPLC-tested, cold-chain shipped, same-day Dubai dispatch.
Buy tesamorelin 5mg in Dubai →

The stack on paper: what UAE researchers actually run

Below is the protocol most commonly logged in UAE peptide research notebooks. This is research framing only — not medical advice, not for human consumption.

VariableTesamorelin armNAD+ arm
Stocked vialTesamorelin 5 mg or 10 mg lyophilizedNAD+ 100 mg lyophilized
Reconstitution3 mL BAC water → 1.67 mg/mL (5 mg vial)2–3 mL BAC water
Typical research dose1–2 mg subcutaneous, evening50–100 mg SC, morning
Cadence5–7 days/week2–3 days/week, cycled
Syringe1 mL insulin syringe, 29G or 31G1 mL insulin syringe, 29G
StorageReconstituted: fridge, ≤28 daysReconstituted: fridge, ≤14 days
Key biomarkerIGF-1 (target upper-normal)Whole-blood NAD+ panel

Note the timing split: tesamorelin in the evening to ride the natural GH peak that occurs in early N3 sleep, NAD+ in the morning so the cofactor lift doesn't compete with sleep onset. This is the most replicated cadence in UAE research logs.

Same-Day Delivery Across UAE — How to Order from REVIVE LAB UAE

REVIVE LAB UAE was built specifically for the peptides UAE researcher who needs cold chain, discretion, and speed. We ship from a Dubai-based cold-storage facility, and same-day or 24h delivery is live for:

Cash on delivery is supported across all seven emirates. Packaging is plain, unbranded, anonymous. No clinical labelling on the outer carton. Every order ships with an ice pack and a foil pouch to preserve vial integrity in UAE summer heat.

Why REVIVE LAB UAE for the tesamorelin + NAD+ stack

REVIVE Peptides UAE is the only UAE-based peptides supplier that publishes per-batch HPLC certificates for every tesamorelin and NAD+ vial sold. We are UAE-based (not a drop-shipper through Europe or Asia), we run our own cold-chain courier, and we keep tesamorelin 5 mg and 10 mg vials in stock alongside NAD+ 100 mg — meaning you can build the full stack in a single order. Discreet packaging, same-day Dubai dispatch, and a 100% replacement guarantee on any vial that arrives compromised. Browse the full catalog at our REVIVE LAB UAE peptides shop.

Reconstitution: the actual math UAE researchers use

For a tesamorelin 5 mg vial reconstituted with 3 mL BAC water (bacteriostatic water): concentration is 1.67 mg/mL. A 1 mg research dose is therefore 60 units on a U-100 insulin syringe (0.6 mL). For a 10 mg vial in 3 mL BAC, concentration is 3.33 mg/mL — same 1 mg dose is 30 units. Use a 29G or 31G needle, rotate SC injection sites (abdomen, lateral thigh), and refrigerate the reconstituted vial. Shelf life of the reconstituted vial in fridge: ~28 days with BAC water's preservative.

For NAD+ 100 mg in 2 mL BAC water: concentration 50 mg/mL. A 50 mg dose is 100 units (1 mL). NAD+ SC stings — pre-mixing with extra BAC and slow injection eases the burn. Reconstituted NAD+ stability is shorter — researchers log a ~14-day fridge window before potency drops.

What the data actually says

Three real trials anchor this stack in the literature:

For NAD+ the mechanistic case rests on SIRT1/SIRT3 cofactor biology and the well-replicated age-related NAD+ decline literature — direct human RCT data on injectable NAD+ is younger, which is exactly why UAE researchers log biomarkers carefully.

Build the full longevity stack in one order.
Tesamorelin 5 mg or 10 mg + NAD+ 100 mg + BAC water 3 mL — in stock now, anonymous packaging, cash on delivery available across the UAE.
Order tesamorelin from REVIVE LAB UAE — the trusted peptides supplier in Dubai →

FAQ — Tesamorelin + NAD+ in the UAE

Q1. Where can I buy tesamorelin in the UAE with same-day delivery?

REVIVE LAB UAE stocks tesamorelin 5 mg and 10 mg vials with same-day cold-chain courier across Dubai, Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, Umm Al Quwain, and Al Ain. Order before 4 PM Dubai time for same-day dispatch; cash on delivery and discreet packaging are standard.

Q2. Why pair tesamorelin with NAD+ instead of running tesamorelin alone?

Tesamorelin drives pulsatile GH/IGF-1 to reduce visceral fat (Stanley 2014). The downstream repair pathways — sirtuins, mitochondrial biogenesis — are NAD+-dependent. Adding NAD+ restores the cofactor pool that declines with age, so the same GH pulse produces more downstream effect. The two operate on complementary axes.

Q3. Is the REVIVE LAB UAE vial HPLC-tested?

Yes. Every batch of REVIVE Peptides UAE tesamorelin and NAD+ ships with a per-batch HPLC certificate of analysis. Vials are lyophilized, sealed under nitrogen, and shipped with ice pack and foil pouch to protect vial integrity through UAE summer heat.

Research use only. Not for human consumption. Not medical advice. All content is provided for in vitro and laboratory research framing under IRB-style protocols.
References
  1. Stanley TL, Feldpausch MN, Oh J, et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. J Clin Endocrinol Metab. 2014;99(9):3252-3262.
  2. Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-2370.
  3. Falutz J, Mamputu JC, Potvin D, et al. Long-term safety and effects of tesamorelin in HIV-infected patients with abdominal fat accumulation. J Clin Endocrinol Metab. 2010;95(9):4291-4304.
  4. Stanley TL, Fourman LT, Feldpausch MN, et al. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. Lancet HIV. 2019;6(12):e821-e830.